1673-422X
2005 Issue 11
The development of bone-injured markers of metastatic bonetumor
yan wei li ; huang gang ; yuan ji min
yan wei li ; huang gang ; yuan ji min
..............page:878-880
Progress of pharmic therapy for acute promyelocytic leukemia
wei fang ; zhang wei hua
wei fang ; zhang wei hua
..............page:875-878
Progress in therapeutic vaccines for cervical cancer
cao gui ming ; tu ying zuo
cao gui ming ; tu ying zuo
..............page:872-874
Application of RNA interference technique in gastric cancer research
ke shan ; liu bing ya ; zhu zheng gang
ke shan ; liu bing ya ; zhu zheng gang
..............page:869-871
Nuclear factor-κB and chemotherapy for lung cancer
zheng yu long ; zhou jian ying
zheng yu long ; zhou jian ying
..............page:865-868
..............page:862-864
Application of genechip in breast cancer research
sang mei xiang ; geng cui zhi
sang mei xiang ; geng cui zhi
..............page:859-862
Advance in intensity modulated radiation therapy for head and neck tumors
huang guo sen ; hu xue feng
huang guo sen ; hu xue feng
..............page:855-859
Tumor-associated gangliosides in tumor progression
liu feng ; wen fei qiu
liu feng ; wen fei qiu
..............page:813-816
Promoter in gene correction therapy
zou jun ; xu ming
zou jun ; xu ming
..............page:809-813
The application of comparative genomic hybridization in tumors study
zhang ru xia ; xue yong quan ; tao min
zhang ru xia ; xue yong quan ; tao min
..............page:806-809
Advances in systems biology of tumour
zheng zhi guo ; xu shen hua
zheng zhi guo ; xu shen hua
..............page:803-805
Sentinel lymph node biospy in head and neck tumor
zeng quan ; hu guo hua
zeng quan ; hu guo hua
..............page:852-855
Actuality and perspective of radio frequency ablation for tumor
li qiang ; huang nai xiang
li qiang ; huang nai xiang
..............page:849-852
Clinical application of IL-11
zhu yan hong ; pan hong ming
zhu yan hong ; pan hong ming
..............page:845-848
Anti-oncogene expression and apoptosis of tumor cells at low-dose rate irradiation
zhuang hong qing ; wang jun jie
zhuang hong qing ; wang jun jie
..............page:842-844
Multidrug resistance-associated protein 1 and tumor
sun meng ; hu xun ; zheng shu
sun meng ; hu xun ; zheng shu
..............page:839-841
..............page:836-838
Activated B lymphocyte:a new direction for tumor immunotherapy
chen ying ; zhong ling
chen ying ; zhong ling
..............page:833-836
Progress in genetically engineered antibody fragments for tumor biotherapy
shui zuo ; li guan cheng
shui zuo ; li guan cheng
..............page:830-833
Progress in the strategy of screening for phage antibody libraries
xiao yan ; li guan cheng
xiao yan ; li guan cheng
..............page:826-830
Mitochondrial disfunction and tumour
jin zuo ; ge hai liang
jin zuo ; ge hai liang
..............page:823-826
Expression of thymldine phmphorylase in tumor tissues and it's clinical application
shang yu hong ; li ji chang
shang yu hong ; li ji chang
..............page:819-822
Crosstalk between Wnt and NF-κB signal pathways in tumorigenesis
chen kang jie ; huang jian
chen kang jie ; huang jian
..............page:817-819